| Amiodarone (Intravenous) |
| SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, Coronory Care Unit |
| SCOPE (Staff): Medical, Nursing, Pharmacy |
Printed versions of this document SHOULD NOT be considered up to date / current
Preamble
See Appendix for full version of this Drug Guideline |
Related Documents
References
 |
Alfred Health (2021, May – pending release). Amiodarone Infusion Drug Guideline. Alfred Health. Obtained May 14, 2021 via personal communication. |
|
Barwon Health (2021, February). Amiodarone Drug Protocol. Barwon Health. Obtained May 14, 2021 via personal communication. |
|
Boyce BA, Yee BH. Incidence and severity of phlebitis in patients receiving peripherally infused amiodarone. Critical care nurse 2012;32:27-34 |
 |
CRC Press, Taylor and Francis Group (2021). The Renal Drug Database. Retrieved May 15, 2021, from |
|
Credible Meds. (2021). QTDrugs List. Retrieved May 15, 2021 from |
|
IBM Micromedex (2021). Micromedex DRUGDEX Evaluations - Amiodarone. Retrieved May 15, 2021, from |
|
MIMS Australia. (2021, May). MIMS Online, Cordarone X product information. Retrieved May 15, 2021 from |
|
Norton L, et al. Phlebitis in Amiodarone Administration: Incidence, Contributing Factors, and Clinical Implications. Am J Crit Care November 2013 vol. 22 no. 6 498-505. |
|
Rossi, S. (2021, January). Australian Medicines Handbook. Retrieved May 15, 2021, from |
|
Showkathali R, Earley MJ, Sporton S. Amiodarone induced thrombophlebitis. Emerg Med J. 2006 Aug 23(8):660 |
|
The Society of Hospital Pharmacists of Australia. (2021, April). Australian Injectable Drugs Handbook (8th ed.). Retrieved May 15, 2021 from |
|
Therapeutic Guidelines Limited. (2021, March). Cardiovascular Guidelines. Retrieved May 15, 2021 from |
|
Walters Kluwer. (2021) UpToDate, including Drug Interaction section. Retrieved May 15, 2021, from |
Appendix
| Reg Authority: Medication Safety & Governance Committee (MSGC) |
Date Effective: 02/08/2021 |
| Review Responsibility: Pharmacist - Rotational |
Date for Review: 31/07/2026 |
Amiodarone (Intravenous) - DRG0023 - Version: 7 - (Generated On: 30-04-2025 05:52) |
